Spleen Deficiency Syndrome / Food Stagnation Syndrome / Distention and Fullness, and other Spleen-Stomach Related Diseases
Conditions
Interventions
TCM Syndrome Type:The prescribed medication includes Chinese patent medicines for invigorating the spleen and harmonizing the stomach.
Sponsors
Chengdu Women's and Children's Central Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: 1.Pediatric patients aged 0–18 years.2.Meeting the aforementioned diagnostic criteria for TCM syndrome differentiation (any one type) and Western medicine diagnostic criteria.3.The prescription includes at least one Chinese patent medicine for invigorating the spleen and harmonizing the stomach (e.g., Xiao'er Jianpi Wan, Shenling Baizhu San, Jianpi Xiaoshi Wan, Buzhong Yiqi Wan, etc.).4.The date of consultation is between January 1, 2023, and December 31, 2024.5.Complete electronic medical records and prescription information, including no missing key data such as age, gender, body weight, BMI, TCM syndrome type, Western medicine diagnosis, drug name, usage and dosage, date of consultation, records of efficacy-related symptoms, and results of safety-related examinations (e.g., liver and kidney function, blood routine).
Exclusion criteria
Exclusion criteria: 1.Patients with a history of allergy to any spleen-invigorating and stomach-harmonizing Chinese patent medicine or its ingredients in the prescription.2.Patients complicated with severe organic diseases such as severe hepatic and renal insufficiency, cardiovascular and cerebrovascular diseases, hematological diseases, or immune system diseases.3.Patients with active infectious diseases (e.g., acute gastroenteritis, pneumonia caused by bacterial or viral infection).4.Patients for whom the TCM syndrome type is not clearly defined or the syndrome differentiation description is ambiguous and cannot be accurately classified in the prescription.5.Prescriptions with incomplete records of drug usage and dosage (e.g., no indication of dosage, frequency, or course of treatment) or irrational prescriptions.6.For repeated visits with highly duplicated prescription information (e.g., multiple follow-up records of the same patient with the same diagnosis and the same medication regimen), only the data from the first visit will be retained, and the rest will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Condition of symptom improvement;Changes in symptom score;Clinical outcome; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse reactions;Laboratory parameters; | — |
Countries
China
Contacts
Public ContactYi Deng
Chengdu Women's and Children's Central Hospital
Outcome results
None listed